• 'One Big Beautiful Bill Act' Impact, Artificial Intelligence and Workload, GBA1 Mutations in Parkinson's Disease
    Aug 20 2026

    In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about the impact of the "One Big Beautiful Bill Act" on neurology practice and research, how artificial intelligence is transforming the neurologist's workload, and the relationship between GBA1 mutations and Parkinson's disease.

    Show More Show Less
    5 mins
  • Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence
    Jul 16 2026

    In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.

    Show More Show Less
    5 mins
  • American Board of Psychiatry and Neurology Academic Pathway, EpiWatch App, Multiplexed MR Scanning
    Aug 6 2026

    In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a pilot American Board of Psychiatry and Neurology Academic Pathway, a study of the EpiWatch app, and a new approach to magnetic resonance scanning.

    Show More Show Less
    5 mins
  • OCEANIC-STROKE Study Results, High-Dose Flu Vaccine and Alzheimer's Risk, Role of Osteopathic Medicine in Neurology
    Jul 2 2026

    In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about asundexian reducing recurrent ischemic stroke, the link between the high-dose flu vaccine and Alzheimer's dementia incidence, and the evolving role of osteopathic medicine in neurology.

    Show More Show Less
    5 mins
  • Wait Times for New Neurology Visits, Post-Traumatic Headache Severity in Children, New Drug for Alzheimer's Agitation
    Jun 18 2026

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about appointment wait times for commercially insured patients, post-traumatic headache severity in children with a family history of migraine, and the FDA approval of a drug for Alzheimer's agitation.

    Show More Show Less
    5 mins
  • Meat Intake and Cognitive Decline, Geographic Distribution of Research Funding, Artificial Intelligence's Role in Neurology
    Jun 4 2026

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a link between higher meat and slower cognitive decline in APOE34/44 carriers, the geographic distribution of research funding, and how artificial intelligence is reshaping neurology.

    Show More Show Less
    5 mins
  • New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk
    May 21 2026

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.

    Show More Show Less
    5 mins
  • Neurology Match Day Growth, Diabetes and Dementia Risk, Public Health Discourse
    May 7 2026

    In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the increase in neurology residency matches this year, the risk of dementia in people with Type 1 diabetes, and the role of neurologists in the public health conversation.

    Show More Show Less
    5 mins